Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250522003) titled 'A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Nebivolol 5 mg Tablets and Reference Product (NEBILET) in Healthy Thai Volunteers under Fasting Conditions' on May 22.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: International Bio Service Co., Ltd.

Condition: Bioequivalence study in healthy Thai male volunteers Bioequivalence Study of Generic Nebivolol 5 mg Tablets and Reference Product (NEBILET) in Healthy Thai Volunteers under Fasting Conditions Bioequivalence Study of Generic Nebivolol 5 mg Tablets and Reference Product (NEBILET) in Healthy Th...